Although FH is a tumor suppressor (i.e., FH mutations result in hereditary leiomyomatosis and renal-cell cancer) and fumarate is proposed to function as an oncometabolite (Yang et al., 2013), the role of FH in leukemic transformation remains unknown. The gene discussed is FH; the disease is hereditary leiomyomatosis and renal cell cancer.